Skip to content

Device to Reduce Surgery Site Contamination - Spine

Reduction of Airborne Microbes in the Surgical Field During Spine Procedures Using Directed Local Airflow

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01262105
Enrollment
23
Registered
2010-12-17
Start date
2009-11-30
Completion date
2010-12-31
Last updated
2012-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

CFU, surgery site

Brief summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g. bacteria) present at a surgery site during spinal procedures.

Detailed description

The Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the Air Barrier System can reduce the presence of airborne colony-forming units at the surgery site during spinal procedures.

Interventions

Device is deployed adjacent to the surgery site and activated so that the filtered air emits over the site.

Sponsors

Nimbic Systems, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Candidate for instrumented posterior lumbar interbody fusion

Exclusion criteria

* Prior history of infection * Revision surgery * Screens positive for MRSA

Design outcomes

Primary

MeasureTime frameDescription
Surgery Site CFU DensityTen-minute intervals throughout procedureCFU culture counts for samples taken in surgery.

Countries

United States

Participant flow

Participants by arm

ArmCount
No Device13
Device Deployed10
Total23

Baseline characteristics

CharacteristicNo DeviceDevice DeployedTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants3 Participants8 Participants
Age, Categorical
Between 18 and 65 years
8 Participants7 Participants15 Participants
Region of Enrollment
United States
13 participants10 participants23 participants
Sex: Female, Male
Female
7 Participants5 Participants12 Participants
Sex: Female, Male
Male
6 Participants5 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 130 / 10

Outcome results

Primary

Surgery Site CFU Density

CFU culture counts for samples taken in surgery.

Time frame: Ten-minute intervals throughout procedure

ArmMeasureValue (MEAN)
No DeviceSurgery Site CFU Density3.08 CFU/m3
Device DeployedSurgery Site CFU Density1.73 CFU/m3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026